The role of Hippo pathway in colorectal cancer (CRC) initiation and progression has been controversial. In this issue of Cell Stem Cell, Cheung et al. (2020) shed new light on a distinct function of the transcriptional co-activator YAP as a tumor suppressor and Wnt pathway inhibitor in CRC.
The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer / Veschi, V.; Stassi, G.. - In: CELL STEM CELL. - ISSN 1934-5909. - 27:4(2020), pp. 501-502. [10.1016/j.stem.2020.09.007]
The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer
Veschi V.;
2020
Abstract
The role of Hippo pathway in colorectal cancer (CRC) initiation and progression has been controversial. In this issue of Cell Stem Cell, Cheung et al. (2020) shed new light on a distinct function of the transcriptional co-activator YAP as a tumor suppressor and Wnt pathway inhibitor in CRC.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
